News & Updates

A planned start appears to be the best strategy for initiating peritoneal dialysis (PD) in patients with end-stage kidney disease (ESKD), but an early start is a good alternative if a planned start is not possible, suggests a Singapore study. In addition, catheter migration may be more frequent with early-start PD, but it does not seem to affect technique survival.

Use of colchicine provides a good balance between benefit and risk in patients with cutaneous polyarteritis nodosa without peripheral sensory neuropathy, reports a study. In the event of relapse, the best treatment appears to be the combination of glucocorticoids and azathioprine.

Lower-sodium oxybate – a new oxybate treatment with 92-percent less sodium than sodium oxybate – continued to demonstrate its potential in improving function, productivity, and sleepiness in individuals with idiopathic hypersomnia, according to data presented at AAN 2022.

New drug applications approved by US FDA as of 16-30 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A novel wearable device can accurately measure range of motion (ROM) and gait in patients who had undergone total knee replacement (TKR), according to a recent study. This proposed system could facilitate portable progress monitoring in this population.

There are no COVID-19 cases documented in patients with solid tumours at 1-year post-vaccination with the BNT162b2 vaccine as shown in a prospective study from Israel.